Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Rozibafusp alfa by Amgen for Systemic Lupus Erythematosus: Likelihood of Approval
Rozibafusp alfa is under clinical development by Amgen and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData,...